Fenebrutinib Uses, Dosage, Side Effects and more
Fenebrutinib is under investigation in clinical trial NCT03174041 (A Drug-Drug Interaction Study Between GDC-0853 and Midazolam, Itraconazole, Rosuvastatin, and Simvastatin).
| Attribute | Details |
|---|---|
| Trade Name | Fenebrutinib |
| Generic | Fenebrutinib |
| Fenebrutinib Other Names | Fenebrutinib |
| Type | |
| Formula | C37H44N8O4 |
| Weight | Average: 664.811 Monoisotopic: 664.348551929 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
